Showing results (171-180 of 226) with videos related to

Sort By:
Pageof 23
Frontiers in Immunology|October 20, 2017
TBVAC2020: Advancing Tuberculosis Vaccines from Discovery to Clinical DevelopmentStefan H E Kaufmann, Hazel M Dockrell, Nick Drager, et al.
Tuberculosis (Edinburgh, Scotland)|December 20, 2014
Genetic diversity of Mycobacterium tuberculosis isolated from tuberculosis patients in the Serengeti ecosystem in TanzaniaErasto V Mbugi, Bugwesa Z Katale, Keith K Siame, et al.
The Journal of Infectious Diseases|September 2, 2011
BCG vaccination induces different cytokine profiles following infant BCG vaccination in the UK and MalawiMaeve K Lalor, Sian Floyd, Patricia Gorak-Stolinska, et al.
Frontiers in Immunology|March 8, 2021
Monitoring Anti-tuberculosis Treatment Response Using Analysis of Whole Blood Mycobacterium tuberculosis Specific T Cell Activation and Functional MarkersMolly A Vickers, Fatoumatta Darboe, Caleb N Muefong, et al.
Plos One|May 6, 2016
Mapping of Mycobacterium tuberculosis Complex Genetic Diversity Profiles in Tanzania and Other African CountriesErasto V Mbugi, Bugwesa Z Katale, Elizabeth M Streicher, et al.
Clinical and Vaccine Immunology : CVI|November 29, 2013
Identification of immunological biomarkers which may differentiate latent tuberculosis from exposure to environmental nontuberculous mycobacteria in childrenYun-Gyoung Hur, Amelia C Crampin, Christina Chisambo, et al.
BMC Infectious Diseases|April 9, 2014
Factors affecting immunogenicity of BCG in infants, a study in Malawi, The Gambia and the UKYun-Gyoung Hur, Patricia Gorak-Stolinska, Maeve K Lalor, et al.
Memorias Do Instituto Oswaldo Cruz|January 4, 2013
Identification of serological biomarkers of infection, disease progression and treatment efficacy for leprosyJohn S Spencer, Malcolm S Duthie, Annemieke Geluk, et al.
Rheumatology Advances in Practice|April 13, 2026
Development of the UK Rheumatology Occupational Therapy Capabilities Framework: a national consensus initiativeYeliz Prior, William J Gregory, Simone Battista, et al.
Clinical and Vaccine Immunology : CVI|August 30, 2013
Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCGHelen A Fletcher, Rachel Tanner, Robert S Wallis, et al.
Pageof 23